Page 96 - 79_03

Javier
Sánchez-­-Rubio
Fernández
&
col.

30. Clark
L,
et
al.
Ideal
vial
size
for
bortezomib:
real-­-world
data
on
waste
and
cost
reduction
in

treatment
of
multiple
myeloma
in
Brazil.
Value
Health.
2011;(5
Suppl
1):S82-­-4.

31. Agemed.
Ficha
Técnica
Velcade®.
(acceso
agosto
2012).

32. André
P,
et
al.
Stability
of
bortezomib
1-­-mg/mL
solution
in
plastic
syringe
and
glass
vial.

Ann
Pharmacother.
2005;39(9):1462-­-6.

33. Walker
SE,
et
al.
Stability
of
bortezomib
reconstituted
with
0.9%
sodium
chloride
at
4ºC

and
room
temperature
(23ºC).
Cn
J
Hosp
Pharm
2008;61(1):14-­-20.

34. Bolognese
A,
et
al.
An
NMR
Study
of
the
bortezomib
degradation
under
clinical
use

conditions.
Adv
Hematol.
2009;2009:704928.

35. Vanderloo
JP,
et
al.
Stability
of
unused
reconstituted
bortezomib
in
original
manufacturer

vials.
J
Oncol
Pharm
Pract.
2011;17(4):400-­-2.

36. Perissutti
M,
et
al.
Etude
de
la
stabilité
d'une
solution
de
bortézomib
à
1
mg/mL

conditionnée
en
seringue
de
polypropylène.
Congrès
SFPO
2011.

37. Sánchez-­-Rubio
Ferrández
J,
et
al.
Extended
stability
of
bortezomib.
Hospital
Pharmacy

Europe
2010;
49:17-­-8.

38. De
Giorgi
I,
et
al.
Sterility
validity
period
of
vials
after
multiple
sampling
under
vertical

laminar
airflow
hood.
J
Oncol
Pharm
Pract.
2005;11(2):57-­-62.

39. Roy
JJ,
et
al.
Study
of
microbiological
safety
of
25
oncology
drugs
after
multiple
uses
in

aseptic
conditions.
Int
J
Pharm
Compd
2011;15(5):428-­-34.

40. Holmes
CJ,
et
al.
Viability
of
microorganisms
in
fluorouracil
and
cisplatin
small-­-volume

injections.
Am
J
Hosp
Pharm.
1988;
45:1089-­-91.

41. Patel
K,
et
al.
Microbial
inhibitory
properties
and
stability
of
topotecan
hydrochloride

injection.
Am
J
Health
Syst
Pharm.
1998;55(15):1584-­-7.

42. Kawamura
K.
The
media
fill
(simulation)
test
is
the
best
method
to
evaluate
aseptic

processing.
PDA
J
Pharm
Sci
Technol
2002;56:57-­-8.

43. Trissel
LA,
et
al.
Using
a
medium-­-fill
simulation
to
evaluate
the
microbial
contamination

rate
for
USP
medium-­-risk-­-level
compounding.
Am
J
Health
Syst
Pharm
2005;62(3):285-­-8.

44. Trissel
LA,
et
al.
Effect
of
two
work
practice
changes
on
the
microbial
contamination
rates

of
pharmacy-­-compounded
sterile
preparations.
Am
J
Health
Syst
Pharm.
2007;64(8):837-­-
41.

480